Johnson & Johnson vaccine details: Colombia would vaccinate nine million with it

On March 25, it was learned that Invima had granted Colombia the emergency use permit of the Ad26.COV2.S vaccine developed by the Johnson & Johnson pharmaceutical company. A Colombian, who was part of the clinical trials of this substance, related his experience, and referred to the efficacy of the drug.

Juan Óscar Barrios, who received the dose, spoke with Noticias Caracol, and explained that he was close to the virus when his wife was infected, “They did the test a week later and I came out negative. Then nothing ever happened to me, I never had any symptoms, no cold, no sore throat, absolutely nothing ”.

According to his account, his wife acquired the virus in parallel with her vaccination process but, thanks to her immunization, granted by that laboratory, she did not become infected.

According to the director of the National Institute for Food and Drug Surveillance (Invima), Julio César Aldana, He assured that Juan is part of the group of more than five thousand people who volunteered, in November 2o20, to receive the injection and, given the positive results, they did not rule out the use of it.

“He has already completed clinical trials in Colombia, with the participation of more than 5,800 volunteers in different institutions in the national territory so we know more closely the scientific data “, explained Julio César Aldana, director of the institute.

For that newscast, Humberto Reynales, executive director of the CAIMED Medical Research Center, spoke, which, in his opinion, is a substance whose evolution “It has been very satisfactory in terms of safety.”

“At the time of its use and application, normal refrigerators are used, from 2 to 8 degrees Celsius, so it is a great advantage because it is a vaccine that will be able to reach other types of populations”, assured the expert.

In the middle of the panel discussion opened by the Canal Caracol newscast, Carlos Álvarez, an epidemiologist, stated that, among other advantages of the vaccine, “Only one dose is required to achieve immunity, this immunity is with an efficiency above 70% and for severe and severe cases close to 100%”.

According to the Colombian president, Iván Duque, by April 17, it is expected that about 3 million people will already be vaccinated against the coronavirus. From the Johnson & Johnson laboratory, the country has purchased 9 million doses.

In the Prevention and Action program of the national president, Aldana released the news after explaining that, “In its capacity as a regulatory agency, Invima has issued the authorization for the emergency use of this vaccine from the pharmaceutical company Janssen, of the multinational Johnson & Johnson”.